Added to YB: 2026-08-17
Pitch date: 2026-08-14
WGS [neutral]
GeneDx Holdings Corp.
-9.26%
current return
Author Info
No bio for this author
Company Info
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.
Market Cap
$2.7B
Pitch Price
$77.39
Price Target
N/A
Dividend
N/A
EV/EBITDA
-108.49
P/E
-24.80
EV/Sales
6.00
Sector
Health Care Providers and Services
Category
turnaround
3 Small-Caps in 3 Minutes #10 - Mexican Investor - GeneDx Holdings Corp.
WGS (quick overview): Rare disease genomic testing w/ 1M+ exome/genome database creating data flywheel. Stock -65% from Nov highs after reimbursement cuts forced 2026 rev guide cut ($540-555M to $475-490M). But demand strong: record 30,785 tests (+32% YoY). Trades 4.6x fwd EV/S vs 6x industry median, NTRA & GH higher. Author sees temporary problem, market too pessimistic. $2.46B mkt cap, $34.9M net debt.
Read full article (1 min)